Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the reporting period of August 2024. The document specifically details a transaction in the company's own shares executed on August 2, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on the mechanics of a specific share repurchase transaction.
| Metric | Value |
|---|---|
| Date of Purchase | August 2, 2024 |
| Number of Shares Purchased | 409,279 |
| Highest Price Paid per Share | 368.50 pence |
| Lowest Price Paid per Share | 360.50 pence |
| Volume Weighted Average Price | 365.5011 pence |
| Registered Share Capital Post-Settlement | 9,131,891,825 ordinary shares |
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 409,279 ordinary shares purchased for cancellation. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the Market Abuse Regulation. It notes that a full breakdown of individual trades is available via a provided link to comply with Regulation (EU) No 596/2014.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the Buyback Programme since its announcement on August 1, 2024.
- Confirm the updated total registered share capital of 9,131,891,825 ordinary shares for disclosure threshold calculations.
- Review the full trade breakdown at the provided London Stock Exchange link for granular transaction data.
- Note that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial metrics.